GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adimmune Corp (TPE:4142) » Definitions » Deferred Policy Acquisition Costs

Adimmune (TPE:4142) Deferred Policy Acquisition Costs


View and export this data going back to 2010. Start your Free Trial

What is Adimmune Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Adimmune Business Description

Industry
Traded in Other Exchanges
N/A
Address
Tanxing Road, No. 3, Section 1, Tanzi District, Taichung, TWN, 427003
Adimmune Corp is a Taiwan-based company. It is engaged in the development, manufacture, and distribution of vaccines and other biological products. Its pipeline consists of products like AdimFlu-S (QIS) which is a vaccine intended for use in the prevention of influenza, and TetraFlu among others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the USA, China, and other regions.